Shujun Xu

Dr. Shujun Xu


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2018 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
YWYuanyuan Wang
Yuanyuan Wang
QWQinwen Wang
Qinwen Wang
XBXiaoming Bao
Xiaoming Bao
YDYanfei Ding
Yanfei Ding
JSJieyi Shentu
Jieyi Shentu
SXShujun Xu
Shujun Xu

12 February 2019 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
YDYanfei Ding
Yanfei Ding
XBXiaoming Bao
Xiaoming Bao
LLLifeng Lao
Lifeng Lao
YLYunxiang Ling
Yunxiang Ling
QWQinwen Wang
Qinwen Wang
SXShujun Xu
Shujun Xu
P-hydroxybenzyl alcohol (HBA) is one of the major components of Gastrodia elata Blume (GEB) phenolic compound. HBA has been reported to have a protective effect on amyloid-β (Aβ) induced cell death. However, the systemic effects and the detail molecu

9 November 2020 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
LLLiping Li
Liping Li
MMMiao Miao
Miao Miao
JCJiarui Chen
Jiarui Chen
ZLZhitao Liu
Zhitao Liu
WLWanyi Li
Wanyi Li
QWQinwen Wang
Qinwen Wang

24 January 2014 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
SXShujun Xu
Shujun Xu
GLGuilan Liu
Guilan Liu
XBXiaoming Bao
Xiaoming Bao
JWJie Wu
Jie Wu
SLShaomin Li
Shaomin Li
QWQinwen Wang
Qinwen Wang
Rosiglitazone has been known to attenuate neurodegeneration in Alzheimer's disease (AD), but the underlying mechanisms remain to be fully elucidated. In this study, living-cell image, immunocytochemistry, and electrophysiology were used to examine th

10 July 2015 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
LJLiting Jiang
Liting Jiang
MHMeng Huang
Meng Huang
SXShujun Xu
Shujun Xu
YWYu Wang
Yu Wang
PAPengyuan An
Pengyuan An
QWQinwen Wang
Qinwen Wang

24 June 2020 in Frontiers in Aging Neuroscience
Verified
Journal Article
Open access
PDF file
CFChenxi Feng
Chenxi Feng
XBXiaoming Bao
Xiaoming Bao
LSL.S. Shan
L.S. Shan
YLYunxiang Ling
Yunxiang Ling
YDYanfei Ding
Yanfei Ding
SXShujun Xu
Shujun Xu
Calcium-sensing receptor (CaSR) is a G protein-coupled receptor (GPCRs). Soluble β-amyloid peptide (Aβ) is one of the orthosteric modulators of CaSR, while, the role and underlying mechanism of CaSR in cognitive decline in Alzheimer’s disease (AD) is unclear. In this study, molecular technology such as live-cell imaging combined with behavioral tests were used to explore the role and the underlying mechanism of CaSR in the cognitive deficits in AD mice. The expression levels of CaSR were increased both in AD mice and Aβ1–42 (β-amyloid protein)-treated primary cultured neurons. Pharmacological inhibition of CaSR ameliorated recognitive and spatial memory deficits of Aβ1–42-oligomer-treated mice in a dose-dependent manner. Pharmacological inhibition of CaSR or down-regulation of the expression of CaSR by CaSR-shRNA-lentivirus prevented the impairment of filopodia, and the synapse induced by oligomeric Aβ1–42. The contents of cytosolic phospholipase A2 (cPLA2) and prostaglandin E2 (PGE2) in hippocampal neurons and tissue were increased after treatment with Aβ1–42 oligomers. Inhibition or down-regulation of CaSR mediates Aβ-induced synapse formation and cognitive deficits partially, through the activation of the cPLA2/PGE2 pathway. This study provides novel insights on CaSR, which is a promising therapeutic target for AD.